Back to Search
OSCIRIAH PRESS, M.D.
M.D.
Hospitalist Physician
NPI: 1689061723IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hospitalist PhysicianPrimary
Hospitalist
Code: 208M00000X
079437(GA)0101275076(VA)
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
0101275076(VA)079437(GA)
Education
LOYOLA UNIVERSITY OF CHICAGO, STRITCH SCHOOL OF MEDICINE
Class of 2015
Research & Publications (20)
131I anti-CD45 radioimmunotherapy effectively targets and treats T-cell non-Hodgkin lymphoma.
PMID 19332764·Blood·2009
7-preclinical
Pretargeting CD45 enhances the selective delivery of radiation to hematolymphoid tissues in nonhuman primates.
PMID 19515724·Blood·2009
4-observational
Biodistributions, myelosuppression, and toxicities in mice treated with an anti-CD45 antibody labeled with the alpha-emitting radionuclides bismuth-213 or astatine-211.
PMID 19244101·Cancer Res·2009
7-preclinical
A comparative analysis of conventional and pretargeted radioimmunotherapy of B-cell lymphomas by targeting CD20, CD22, and HLA-DR singly and in combinations.
PMID 19124831·Blood·2009
4-observational
Pretargeted radioimmunotherapy using anti-CD45 monoclonal antibodies to deliver radiation to murine hematolymphoid tissues and human myeloid leukemia.
PMID 19118002·Cancer Res·2009
7-preclinical
A re-examination of radioimmunotherapy in the treatment of non-Hodgkin lymphoma: prospects for dual-targeted antibody/radioantibody therapy.
PMID 19182204·Blood·2009
7-preclinical
Extracorporeal adsorption therapy: a method to improve targeted radiation delivered by radiometal-labeled monoclonal antibodies.
PMID 18454687·Cancer Biother Radiopharm·2008
7-preclinical
Rituximab blocks binding of radiolabeled anti-CD20 antibodies (Ab) but not radiolabeled anti-CD45 Ab.
PMID 18502830·Blood·2008
7-preclinical
Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells.
PMID 18509084·Blood·2008
3-trial
Radiolabeled and native antibodies and the prospect of cure of follicular lymphoma.
PMID 18586921·Oncologist·2008
6-review
High-dose therapy and autologous stem cell transplantation for chemoresistant Hodgkin lymphoma: the Seattle experience.
PMID 18623377·Cancer·2008
3-trial
Gender-related survival differences associated with EGFR polymorphisms in metastatic colon cancer.
PMID 18413774·Cancer Res·2008
8-other
Antigen sensitivity of CD22-specific chimeric TCR is modulated by target epitope distance from the cell membrane.
PMID 18453625·J Immunol·2008
8-other
Effect of remission status and induction chemotherapy regimen on outcome of autologous stem cell transplantation for mantle cell lymphoma.
PMID 18452065·Leuk Lymphoma·2008
8-other
Evidence mounts for the efficacy of radioimmunotherapy for B-cell lymphomas.
PMID 18854559·J Clin Oncol·2008
8-other
Myeloablative 131I-tositumomab radioimmunotherapy in treating non-Hodgkin's lymphoma: comparison of dosimetry based on whole-body retention and dose to critical organ receiving the highest dose.
PMID 18413376·J Nucl Med·2008
4-observational
High-dose chemotherapy with BEAM or Busulphan/Melphalan and Thiotepa followed by hematopoietic cell transplantation in malignant lymphoma.
PMID 18949614·Leuk Lymphoma·2008
4-observational
Eradication of disseminated leukemia in a syngeneic murine leukemia model using pretargeted anti-CD45 radioimmunotherapy.
PMID 18042793·Blood·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 35 COLLIER RD NW STE 635
ATLANTA, GA 30309 - Phone
- (404) 367-3014
Quick Facts
- NPI
- 1689061723
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 4
- Locations
- 3
- Years in Practice
- 11
- Publications
- 20
Are you this provider?
Claim Your Profile